<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02765087</url>
  </required_header>
  <id_info>
    <org_study_id>EN002</org_study_id>
    <nct_id>NCT02765087</nct_id>
  </id_info>
  <brief_title>E-Nose: Diagnostic Tool for Pleural TB</brief_title>
  <official_title>Diagnostic Utility of the E-Nose for Pleural TB</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Central de Venezuela</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The ENose Company, Zutphen, Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación Para la Investigación en Micobacterias (FUNDAIM)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Central de Venezuela</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the diagnostic utility of the device 'Electronic
      Nose' for Pleural TB, which is a Extra pulmonary TB form, compared with pleural biopsy, the
      current gold standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to determine the diagnostic utility of the device 'Electronic Nose'
      for Pleural TB, which is a Extra pulmonary TB form.

      The patient who qualified for the study, according to the inclusion criteria, after
      consenting, will be guided through and oriented survey for risk factors, then a complete
      physical exam, and after that, the patient will breathe for 5 minutes trough the device,
      which stores the patient information, that later will be download to a computer and will be
      send to the server's manufacturer company, in Netherlands.

      During and after the use of the device, investigators determine the adverse effects of the
      intervention, according to the CTCEA.

      Investigators use the pleural biopsy, which is the gold standard, to determine the diagnostic
      utility of the test. And, will compare the results with other tests currently perform as the
      regular diagnostic routine, such as Chest CT, adenosine deaminase value of pleural fluid and
      cytomorphologic &amp; cytochemistry of the pleural fluid.

      Patient Registries will be keep in an electronic database, as well as handwriting history,
      with the backup copy in the records of the hospital in which the patient was admitted.

      Auditories will be realised by the Ethics Committee in different time frames.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity of the device for the diagnosis of Tuberculosis Pleural effusion</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Effects related to the use of the device, according to the CTCEA</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Tuberculosis, Pleural</condition>
  <arm_group>
    <arm_group_label>Pleural TB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group consist of patients with TB pleural effusion.
Intervention:
Inform Consent
Medical History
E-Nose Device
Chest CT
Cytomorphologic &amp; Cytochemistry of pleural Fluid.
Adenosine Deaminase value of pleural Fluid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with pleural effusion with different aetiologies than Tuberculosis.
Intervention:
Inform Consent
Medical History
E-Nose Device
Chest CT
Cytomorphologic &amp; Cytochemistry of pleural Fluid.
Adenosine Deaminase value of pleural Fluid.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical History</intervention_name>
    <description>Oriented Survey and complete physical exam.</description>
    <arm_group_label>Pleural TB</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E-Nose</intervention_name>
    <description>Patient will breath trough the device for 5 minutes, and during and after the intervention will be assessed for adverse effects related to the use of the e-Nose, according to the CTCEA</description>
    <arm_group_label>Pleural TB</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chest CT</intervention_name>
    <arm_group_label>Pleural TB</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pleural Fluid Analysis</intervention_name>
    <description>Cytomorphology Cytochemistry Adenosine Deaminase Value</description>
    <arm_group_label>Pleural TB</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Accept to participate in the study through a signed informed consent approved by the
             Ethical Committee of our Institution.

          2. More than 15 years old.

          3. Pleural effusion of any etiology

        Exclusion Criteria:

          1. Severe compromise of the general condition

          2. Not capable to exhaled through the E-nose.

          3. No possibility to follow-up.

          4. By discretion of the research team.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacobuss de Waard, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Biomedicina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sergio Poli, MD</last_name>
    <phone>+584265172608</phone>
    <email>sergio.polid@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto de Biomedicina</name>
      <address>
        <city>Caracas</city>
        <state>DC</state>
        <zip>1020</zip>
        <country>Venezuela</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Poli, MD</last_name>
      <phone>+584265172608</phone>
      <email>sergio.polid@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jacobus de Waard, PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luisa Quesada, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergio Poli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emines Salas, BsBio</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Poli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Venezuela</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2016</study_first_posted>
  <last_update_submitted>November 12, 2017</last_update_submitted>
  <last_update_submitted_qc>November 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Central de Venezuela</investigator_affiliation>
    <investigator_full_name>Jacobus H. de Waard</investigator_full_name>
    <investigator_title>Chief of Tuberculosis Laboratory</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pleural</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

